James B Breitmeyer's Net Worth
$7.37 Million
Who is James B Breitmeyer?
James B Breitmeyer has an estimated net worth of $7.37 Million. This is based on reported shares across multiple companies, which include APPLIED MOLECULAR EVOLUTION INC, ZOGENIX, INC., Oncternal Therapeutics, Inc., OTONOMY, INC., and CADENCE PHARMACEUTICALS INC.
SEC CIK
James B Breitmeyer's CIK is 0001244823
Past Insider Trading and Trends
2023 was James B Breitmeyer's most active year for acquiring shares with 18 total transactions. James B Breitmeyer's most active month to acquire stocks was the month of May. 2023 was James B Breitmeyer's most active year for disposing of shares, totalling 16 transactions. James B Breitmeyer's most active month to dispose stocks was the month of September. 2019 saw James B Breitmeyer paying a total of $89,900.00 for 580,181 shares, this is the most they've acquired in one year. In 2019 James B Breitmeyer cashed out on 120,000 shares for a total of $500,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
APPLIED MOLECULAR EVOLUTION INC No price found
VP PHARMACEUTICAL OPERATIONS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.36% | 4.91K |
$1.74 | $8,538.18 | 33.17K |
Feb 9
| |||
Form 4
| +28.47% | 6.26K |
$1.74 | $10,899.36 | 28.27K |
Jan 2
| |||
Form 4
| +51.10% | 7.44K |
$2.45 | $18,228.00 | 22K |
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZOGENIX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.25K |
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
$29.50 | -$205,050.00 | 1.25K |
Scheduled
|
Dec 16
| ||
Form 4
|
—
|
0
|
$29.50 | -$205,050.00 | 1.25K |
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
| No matching records found | |||||||||
Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $9.6
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| -10.79% | -55.44K |
$0.50 | -$27,503.79 | 458.46K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
| -9.19% | -52.00K |
$0.36 | -$18,719.64 | 513.9K |
Jul 3
| |||
Form 4
| +322.28% | 150K |
$0.29 | $43,929.75 | 196.54K |
Apr 13 - Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -4.89% | -29.12K |
$1.02 | -$29,700.36 | 565.9K |
Jan 3
| |||
Form 4
| +52.32% | 204.38K |
—
|
—
| 595.02K |
Jul 28
| |||
Form 4
| +116.04% | 25K |
$1.68 | $42,080.00 | 46.54K |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
| +52.96% | 135.35K |
—
|
—
| 390.94K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27 - Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 277.87K |
—
|
—
| 277.87K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OTONOMY, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CADENCE PHARMACEUTICALS INC No price found
EVP, CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||